ARTICLE | Clinical News
VAC-3S: Additional Phase I data
August 10, 2015 7:00 AM UTC
The double-blind, French Phase I IVVAC-3S/P1 trial in about 33 patients with HIV-1 infection receiving antiretroviral therapy (ART) with undetectable viral loads showed that VAC-3S met the primary saf...